[Lipid profile in Venezuelan preschoolers by socioeconomic status]

Emma Velásquez1, María Adela Barón, Liseti Solano

  • 1Centro de Investigaciones en Nutrición Dr. Eleazar Lara Pantin, Facultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Estado Carabobo, Venezuela.

Insights

Children from low socioeconomic status (LSES) exhibit higher atherogenic risk due to unfavorable serum lipid profiles, increasing their risk for cardiovascular disease and atherosclerosis. This highlights the impact of socioeconomic factors on pediatric cardiovascular health.

Area of Science:

  • Pediatric cardiovascular health
  • Nutritional epidemiology
  • Biochemical risk factors

Background:

  • Childhood serum lipid levels are established predictors of adult atherosclerosis.
  • Socioeconomic status significantly influences health outcomes, including cardiovascular risk.
  • Early identification of risk factors in children is crucial for long-term health.

Purpose of the Study:

  • To compare the lipid profiles of Venezuelan preschool children across different socioeconomic statuses.
  • To assess the association between socioeconomic status and atherogenic risk factors in early childhood.
  • To identify potential disparities in cardiovascular disease risk based on socioeconomic background.

Main Methods:

  • Assessed lipid profiles (triglycerides, total cholesterol, HDL-C, LDL-C) in 297 preschool children (4-7 years).
  • Classified participants into high socioeconomic status (HSES) and low socioeconomic status (LSES) groups.
  • Calculated atherogenic risk ratios (TC/HDL-C, LDL-C/HDL-C) and performed nutritional anthropometric evaluations.

Main Results:

  • LSES preschoolers showed significantly higher atherogenic risk compared to HSES children.
  • LSES group exhibited lower HDL-C levels and higher TC/HDL-C and LDL-C/HDL-C ratios.
  • No significant differences in lipid profiles were observed based on nutritional status or gender.

Conclusions:

  • Low socioeconomic status in childhood is significantly associated with an elevated risk for cardiovascular disease and atherosclerosis.
  • Children from LSES backgrounds present a less favorable lipid profile, indicating higher atherogenic risk.
  • Findings underscore the importance of socioeconomic factors in pediatric cardiovascular health and the need for targeted interventions.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...